Michael Aaron Kelly - Insider Trading & Ownership

Location
C/O Hookipa Pharma Inc., 430 East 29 Th St., New York, NY
Summary
The estimated net worth of Michael Aaron Kelly is at least $1.66M dollars as of June 6, 2025. Michael Aaron Kelly is the Director of NEOGENOMICS INC and owns shares of NEOGENOMICS INC (NEO) stock worth about $785K. Michael Aaron Kelly is the Director of AMICUS THERAPEUTICS, INC. and owns shares of AMICUS THERAPEUTICS, INC. (FOLD) stock worth about $450K. Michael Aaron Kelly is the Director of DMC Global Inc. and owns shares of DMC Global Inc. (BOOM) stock worth about $410K. Michael Aaron Kelly is the Director of Aprea Therapeutics, Inc. and owns shares of Aprea Therapeutics, Inc. (APRE) stock worth about $17K.
Signature
/s/ Christian Formica, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Michael Aaron Kelly

Insider Transactions Reported by Michael Aaron Kelly:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.